Clearbridge Health rides on China's biotech boom for cancer diagnostic spinoff

Clearbridge Health rides on China's biotech boom for cancer diagnostic spinoff

By: 
Trinity Chua
31/08/18, 02:05 pm

SINGAPORE (Aug 31): Investors and foreign biotech veterans are making their way to China as the government aims to build a healthcare empire.

Jeremy Yee, former CEO of Cordlife Group and now running his second healthcare company Clearbridge Health, hopes to tap into that optimism. He plans to spin off a cancer diagnostics associate company that is aiming to expand into China, and buy more testing laboratories in the region. Yee hopes these moves will help revive investor interest in Clearbridge.

The company was listed last December; its shares hit 63 cents on Feb 1, but have since fallen more than 62% to close at 24 cents on Aug 30 and 14% below its IPO price of 28 cents.

He is betting on China’s population of 1.4 billion as well as the Chinese government’s seemingly more welcoming policies. There have been initiatives to lower regulatory requirements, provide incentives and attract venture capital into the market.

Venture capital investment in Chinese healthcare rose from US$1 billion in 2013 to US$11.7 billion ($16 billion) in 2017, according to McKinsey & Co. The Chinese healthcare sector is expected to grow 12% annually to reach US$1 trillion in 2020, faster than any other country in the world.

Yee’s group may be in a good position to capitalise on this pace of growth, but competition in China is steep.

Find out more in this week’s issue of The Edge Singapore (Issue 846, week of Sept 3), on sale now at newsstands.

Subscribers can log in and read Clearbridge Health’s cancer diagnostic spin-off targets biotech craze in China

Or click here to subscribe

Najib arrested for alleged tampering of 1MDB report

SINGAPORE (Dec 10): Malaysia’s ex-prime minister, Najib Razak, has been arrested yet again by the Malaysian Anti-Corruption Commission (MACC). But this time, over the “tampering” of the 1Malaysia Development Berhad (1MDB) final audit report. Najib arrived at the MACC headquarters earlier today at 10.40am, apparently to assist in investigations regarding the above allegations. He was later arrested at about 11.00am. At around 1.20pm, Najib was released after posting bail. MACC is believed to charge Najib and former 1MDB president Arul Kanda this Wednesday over the alleged tamperi....
Read More >>

Singapore authorities block New Noble listing

SINGAPORE (Dec 10): The Monetary Authority of Singapore (MAS) and Singapore Exchange Regulation (SGX RegCo) have barred Noble Group from transferring its listing status to New Noble as part of its restructuring process. This comes after a “careful review” of the findings to-date from the ongoing investigations into the commodities trader and its Singapore-incorporated subsidiary Noble Resources International (NRI). According to a joint statement by MAS, the Commercial Affairs Department (CAD) and SGX RegCo, the decision to block the New Noble listing arose from doubts about New Noble’....
Read More >>

Balancing profit and motive

SINGAPORE (Dec 10): On Dec 5, the UK government published a trove of internal Facebook emails and other documents that suggested the social media platform sought to trade users’ data with advertisers, or wield it for strategic advantage with third-party applications. Facebook has been under increasing scrutiny amid privacy concerns, and the backlash to the news was to be expected. In its defence, Facebook said it was seeking a way to ensure the sustainability of its business. As a business, Facebook should indeed be looking for the best way to monetise or leverage its assets — users’ ....
Read More >>
Active management can deliver attractive returns amid tightening liquidity, says Charles Schwab

SINGAPORE (Dec 10): In the last few years, passive fund management has become increasingly popular a